Performance & Endurance Peptides (4 Offers)
Peptides studied for enhancing aerobic capacity, stamina, and metabolic efficiency. This category focuses on AICAR and other compounds researched for their effects on AMPK activation, fat utilization, and endurance adaptation.
INSULIN-LIKE GROWTH FACTOR 1 LR3 1 MG INJECTION
Drug Class: Long R³ Insulin-like Growth Factor-I
Composition:
- Active Substance: Insulin-like Growth Factor 1 LR3
- Concentration: 1 mg/vial
Presentation: 2 mL Vial
Form: Lyophilized Powder
Manufacturer: Dragon Pharma
Tested in Laboratory: View Lab Report
Peptides in Athletic Performance and Endurance Research
Performance and endurance peptides are investigated for their potential to modulate energy metabolism and improve physiological adaptations to exercise. This research area focuses on compounds that activate key metabolic pathways, such as AMPK (AMP-activated protein kinase), to enhance cellular energy efficiency, increase fat oxidation, and improve aerobic capacity in experimental models.
The primary research compound in this category is:
- AICAR (AICA Ribonucleotide): A direct activator of the AMPK pathway, often described as a "metabolic exercise mimetic." It is a central subject in studies investigating endurance adaptation without physical training. Research focuses on its role in promoting glucose uptake, mitochondrial biogenesis, and shifting substrate utilization towards fats, which are critical factors in stamina and fatigue resistance.
This category serves researchers studying exercise physiology, sports science, and metabolic disorders. It provides targeted tools to investigate the molecular mechanisms behind energy sensing, endurance training adaptations, and potential interventions for conditions involving metabolic fatigue. The goal is to understand how pharmacological activation of energy pathways can influence performance biomarkers.
All products are supplied strictly for controlled, non-human in vitro research use.